News and Comments

JAKAFI REGRAWS HAIR IN ALOPECIA AREATA. THE DRUG BELONGS TO INCYTE

  Tuesday, August 19, 2014

 More...

OUR REASONS DIFFER INVESTING IN NKTR

  Monday, August 04, 2014

What’s In the Agenda? Technically-oriented analysts sometimes boost small development-stage stocks on news that are not what we meant to hear when we picked these firms to invest in. Although we appreciate the rallying of stocks for whatever reasons, our choice of firms for investment purpose  is based primarily on their validated far-reaching technologies; their pipeline promising products and the professionalism of their management teams.     More...


Recent Postings


Archive


Tags

Velcade (bortezomib) Sequenom (SQNM) Theravance Bio Pharma (TBPH) Valeant Pharmaceuticals International (VRX) Biogen Idec (BIIB) SERES THERAPEUTICS (MCRB) Vitae Pharmaceuticals (VTAE) Anadys (ANDS) NANTKWEST (NK) ADVENTRIX (ANX) JUNO (JUNO) Cytokinetics (CYTK) Ionis (IONS) ImmunoGen (IMGN) ZALTRAP™ Dendreon (DNDN) Endometrial Cancer Exelixis (EXEL) Jazz Pharmaceuticals (JAZZ) Tysabri OSI (OSIP) Mirati Therapeutics (MRTX) Ariad (ARIA) Seattle Genetics (SGEN) ABBVIE (ABBV) VANDA (VNDA) galapagos (GLPG) REGULUS (RGLS) ISIS (ISIS) Sarepta (SRPT) Array Pharmaceuticals (ARRY) Dynavax (DVAX) Biocryst (BCRX) Alder Biopharmaceuticals (ALDR) Zerenex Aimmune Therapeutics (AIMT) GUARDIAN HEALTH BIOMARIN (BMRN) Anacor (ANAC) IDERA (IDRA) Vertex (VRTX) Inovio (INO) Agenus (AGEN Micromet (MITI) Theravance (THRX) Agenus (AGEN) Telaprevir Onyx (ONXX) Prolor Biotech (PBTH) CompuGen (CGEN) Rapamune Roche (RHHBY) Merck (MRK) Genentech Prosensa (RNA) Sanofi (SNY) Elan (ELN) Sanofi (SNA) Amgen (AMGN) Revlimid (lenolidamide) Abbott Laboratories (ABT) Auspex (ASPX) Sangamo (SGMO) Illumina (ILMN) Intercept (ICPT) Ridaforolimus Multiple Myeloma KERYX (KERX) Intermune (ITMN) Human Genome Sciences (HGSI) Benlysta (belimumab) Galena (GALE) Idenix (IDIX) SYNTA (SNTA) ACADIA (ACAD) Sanofi-Aventis (SAN) SUNESIS PHARMACEUTICALS (SNSS) Incyte (INCY) KITE (KITE) Regeneron (REGN) Alnylam (ALNY) GlaxoSmithKline (GSK) Bristol-Myers Squibb (BMY) Ziofpharm (ZIOP) Gilead (GILD) Herceptin HALOZYME (HALO) Xoma (XOMA) Trastuzumab-DM1 Human Longevity (HLI) NEKTAR (NKTR)) ARCA (ABIO) TOKAI (TKAOI) Intrexon (XON) Pluristem (PSTI) C4 Therapeutics AERIE PHARMACEUTICALS Roche (ROCHE)